Navigation Links
ORF Genetics Opens Revolutionary 'Green Factory' in Iceland
Date:5/13/2008

Human growth factors produced in barley grain, using renewable, geothermal energy

REYKJAVIK, Iceland, May 13 /PRNewswire-USNewswire/ -- ORF Genetics (http://www.orfgenetics.com), an Icelandic biotechnology company, announced today the opening of new and revolutionary 22,000 ft^2 (2043m^2) cultivation facilities in Grindavik, Iceland. Utilizing its unique Orfeus(TM) protein production system in barley, ORF Genetics produces and markets biorisk-free ISOkine(TM) human growth factors for use in medical research, drug discovery and cosmetics.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080513/DC22192 )

The state-of-the-art Green Factory uses geothermal energy for safe, indoor cultivation of genetically engineered barley. It is set in the middle of a lava field, close to Icelands best-known tourist attraction, the Blue Lagoon. The barley is cultivated in a soil-less hydroponic system on specially designed conveyor belts, allowing for the production of up to 90 different proteins at a time. The Orfeus(TM) system and new facilities allow ORF the flexibility to easily scale their production according to the unique requirements of different customers and markets. Currently ORF has more than 100 different growth factors in its pipeline and 10 ISOkine(TM) growth factors already on the market.

Bjorn L. Orvar, CEO of ORF Genetics, said at the opening of the greenhouse: "Our research and development efforts in recent years are now bearing fruit, and we see great opportunities for rapid growth, specifically in the field of drug discovery and cosmetics."

Minister of Industry Ossur Skarphedinsson said as he harvested the first barley in the Green Factory: "ORF's ideas have sprouted from the dynamic Icelandic public research environment, and the company's leaders, with unflagging entrepreneurial optimism, have overcome all difficulties, making ORF a unique high-tech company in the world. The new 'Green Factory' leverages the company's deserved green image, as production is based on green and renewable energy from Iceland's volcanic depths."

ORF will be exhibiting their products in the US at the upcoming Supplier's Day Show hosted by the New York Society for Cosmetic Chemists in May.

ORF Genetics

Headquartered in Reykjavik, Iceland, ORF Genetics Ltd. is a privately owned biotech company that is committed to economically viable green technology for the production of growth factors and other hard-to-produce recombinant proteins. Utilizing its unique Orfeus(TM) plant-based expression system, the company is currently producing biorisk-free, high purity ISOkine(TM) products to serve the needs of the medical research, cell culture media, diagnostics and cosmetic markets. ORF was recently awarded the prestigious 2008 Icelandic Innovation Award by the Icelandic Centre for Research and the Icelandic Trade Council.


'/>"/>
SOURCE ORF Genetics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Response Genetics Reports Second Quarter 2007 Financial Results
3. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
4. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
6. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
7. Interleukin Genetics Announces Management and Board Appointments
8. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
9. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
10. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
11. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... UAS ... the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, ... proud to add Target to its list of well-respected retailers. This list includes ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):